A carregar...
The role of RBM10 mutations in the development, treatment, and prognosis of lung adenocarcinoma
RBM10 is the RNA-binding protein often absent or mutated in lung adenocarcinoma, rendering it as a potential biomarker or even therapeutic target to prolongate survival time. In this study, we investigated the involvement of RBM10 mutation in the pathogenesis and tumorigenesis of lung adenocarcinoma...
Na minha lista:
| Publicado no: | Cell Cycle |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7714495/ https://ncbi.nlm.nih.gov/pubmed/33064970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2020.1829801 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|